Skip to content
Rezolute, Inc. logo

Rezolute, Inc. Alternatives & Competitors

12 companies similar to Rezolute, Inc. — Rezolute is developing transformative therapeutics for rare and metabolic diseas...

Companies similar to Rezolute, Inc.

Eiger BioPharmaceuticals logo — alternative to Rezolute, Inc.

Eiger BioPharmaceuticals

Developing innovative therapies to treat and cure rare metabolic diseases

Allena Pharmaceuticals, Inc. logo — alternative to Rezolute, Inc.

Allena Pharmaceuticals, Inc.

Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney Disorders

Soligenix, Inc. logo — alternative to Rezolute, Inc.

Soligenix, Inc.

We are a late-stage biopharmaceutical company focused on developing & commercializing prod...

Eloxx Pharmaceuticals logo — alternative to Rezolute, Inc.

Eloxx Pharmaceuticals

Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat...

Rival Readout

Competing with Rezolute, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Therachon logo — alternative to Rezolute, Inc.

Therachon

Life-Transforming Therapies - Developing novel therapeutics for serious rare conditions

AN2 Therapeutics logo — alternative to Rezolute, Inc.

AN2 Therapeutics

Developing therapies for rare, chronic, and serious infectious diseases

Avalo Therapeutics logo — alternative to Rezolute, Inc.

Avalo Therapeutics

Innovation driven by compassion.

Versantis logo — alternative to Rezolute, Inc.

Versantis

Multiorgan support for rare pediatric and acute liver diseases

VectivBio logo — alternative to Rezolute, Inc.

VectivBio

Biotech company develops treatments for severe rare diseases, aims to become global leader...

Reviva Pharmaceuticals logo — alternative to Rezolute, Inc.

Reviva Pharmaceuticals

Next Generation Therapeutics to successfully address central nervous system, metabolic and...

Intercept Pharmaceuticals logo — alternative to Rezolute, Inc.

Intercept Pharmaceuticals

Our mission is to build a healthier tomorrow for patients with rare and serious liver dise...

X4 Pharmaceuticals logo — alternative to Rezolute, Inc.

X4 Pharmaceuticals

Enabling a better future for people with rare immune disorders

About Rezolute, Inc.

Rezolute, Inc. is a clinical stage biopharmaceutical company founded in 2010, dedicated to the development of innovative drug therapies targeting metabolic and rare diseases. Through its transformative therapeutics, Rezolute aims to significantly enhance the quality of life for patients suffering from these conditions.

Business keywords

Clinical-stage Biopharmaceutical Company, Drug Development, Metabolic Diseases, Orphan Diseases, Therapeutics, Antibody Therapy, Diabetes Management, Rare Diseases, Plasma Kallikrein Inhibitor, Clinical Trials, Biopharma Innovation, Patient-focused Therapies

Frequently Asked Questions

Companies similar to Rezolute, Inc. include Eiger BioPharmaceuticals, Allena Pharmaceuticals, Inc., Soligenix, Inc., Eloxx Pharmaceuticals, Therachon. They work in Biotechnology and Health Care and share Rezolute, Inc.'s focus on drug development, rare diseases and therapeutics.
Bounce Watch lists 12 companies that share Rezolute, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.
Rezolute, Inc. is a clinical stage biopharmaceutical company founded in 2010, dedicated to the development of innovative drug therapies targeting metabolic and rare diseases. Through its transformative therapeutics, Rezolute aims to significantly enhance the quality of life for patients suffering from these conditions.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Rezolute, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Rezolute, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout